2023年6月28日,

全球eConsent醫療市場規模預計將在2030年達到9.0914億美元。市場預計將增長從2023年到2030年的複合年增長率為11.2%。增加采用eConsent在臨床試驗中,加上移動技術的進步,將變換的過程設計、交付和管理知情同意。eConsent提供好處,如改善版本控製、遠程監控和文檔管理。發表的一篇文章的基礎上,由中國臨床題為“法定審查IRB eConsent史”和Signant健康的研究,研究人員使用當前eConsent工具欣賞改進版本控製、文檔管理和遠程監控。數字技術的實現,特別是移動設備,將徹底改變知情同意過程,有利於病人和讚助商通過允許更精確的病人選擇和參與。此外,實施eConsent在臨床試驗中已經證明可以改善病人的理解,從而創造更好的受試者。例如,Signant健康的基礎上的研究文章,eConsent會是一個不錯的機會,增強病人的理解和產生更好的受試者。傳統的列舉了同意表格容易錯誤和缺陷,可以解決標準化,清晰,理解eConsent係統。此外,在臨床試驗中采用eConsent老年參與者預計在2023年和2030年之間大幅上升。 The increased use of eConsent is also driving its integration with other eClinical solutions, supporting market growth. According to the State of eConsent 2020 report by Signant Health, 28% of survey respondents integrated eConsent with EDC products and clinical trial management systems, while 17%, 19%, and 26% integrated eConsent with randomization & trial supply management solutions, electronic trial master file, and electronic clinical outcome assessment, respectively. Companies that acquire or form strategic partnerships with eConsent solution providers and other eClinical companies are expected to gain a competitive advantage across various sectors. These strategic initiatives are projected to bolster market growth over the forecast period. For instance, in June 2022, uMotif and ClinOne announced a partnership to address the challenges faced by patients & clinical research coordinators who struggle to navigate multiple systems, apps, & sensors for each protocol. To overcome these challenges, the two companies aim to provide the life sciences industry with a single, integrated solution that delivers best-in-class Electronic Clinical Outcome Assessments (eCOA) and Electronic Informed Consent (eConsent) technology. eConsent In Healthcare Market Report Highlights The cloud-based segment dominates the market offering substantial benefits to patients, CROs, and medical providers. This segment encompasses private, public, and hybrid cloud deployment models, providing enhanced patient experience, streamlined study execution, and improved compliance. On the other hand, the Web-based segment is anticipated to expand at a CAGR of over 4.5% during the forecast period The remote enrollment segment is expected to experience the fastest growth due to technological advancements and the increased adoption of remote enrollment methods, especially during the COVID-19 pandemic. This trend has significantly contributed to the overall market growth The general consent segment emerged as the market leader in 2022, driven by its widespread adoption in healthcare facilities and clinical trials. This form of consent is favored for routine procedures that carry minimal risks, such as blood sampling, physical examinations, and administering fluids, owing to its simplicity compared to other consent forms North America dominated the eConsent market in 2022, driven by factors such as the introduction of advanced technologies, well-established healthcare facilities, increased clinical trials, and the growing presence of emerging and established market players. These factors have collectively heightened the demand for eConsent solutions in the region Key Attributes: 4.1 Definition and Scope 4.3 Segment Dashboard 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 Chapter 5 eConsent in Healthcare Market Segment Analysis, By Enrollment Type 2018 - 2030 (USD Million) 5.1 Definition and Scope 5.3 Segment Dashboard 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 Chapter 6 eConsent in Healthcare Market Segment Analysis, By Form Type 2018 - 2030 (USD Million) 6.1 Definition and Scope 6.3 Segment Dashboard 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 Chapter 7 eConsent in Healthcare Market Segment Analysis, By Region, 2018 - 2030 (USD Million) 7.1 Definition & Scope 7.3 Regional Market Dashboard